# Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic

> **NCT04367545** · NA · COMPLETED · sponsor: **University Hospital, Rouen** · enrollment: 130 (actual)

## Conditions studied

- COVID
- RT-ddPCR Multiplex

## Interventions

- **DIAGNOSTIC_TEST:** Saliva collection

## Key facts

- **NCT ID:** NCT04367545
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-16
- **Primary completion:** 2020-05-17
- **Final completion:** 2020-05-17
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04367545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04367545, "Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04367545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*